Medical Devices Growth Investors & VC Firms
523 firms in this list, with a median first check of $1.1M. 130 of them lead rounds. Generated from verified public data and updated continuously.
EQT Life Sciences
AmsterdamSeed–Late Stage$11M – $66M
59 people
HLM Investment Partners
WalthamSeries A–Growth$3M – $5M
35 people
SMBC Venture Capital
TokyoPre-Seed–Late Stage
27 people
Tesi (Finnish Industry Investment Ltd)
HelsinkiSeed–Late Stage$5.4M – $16.2M
24 people
BOM
TilburgSeed–Growth$540K – $5.8M
17 people
Artesian
SydneyPre-Seed–Growth$20M
41 people
Eight Roads Ventures
MumbaiSeed–Growth$5M – $30M
33 people
Advent International
BostonGrowth–Late Stage$1.1B
58 people
UntroD Capital
TokyoSeed–Growth
38 people
Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
15 people
Seventure Partners
ParisSeed–Growth
19 people
Holland Capital
AmsterdamGrowth
48 people
Pitango
Tel AvivSeed–Growth$2M – $40M
39 people
M Ventures
AmsterdamSeed–Growth$10.8M
25 people
Atlantic Bridge Ventures
Palo AltoSeed–Growth$1M – $5M
42 people
TRANSFORMATION CAPITAL
BostonGrowth
26 people
HealthCap
StockholmSeed–Growth
33 people
FFL Partners
San FranciscoGrowth$50M – $200M
57 people
Ascension Ventures
Saint LouisSeed–Late Stage$10M – $20M
18 people
Nextech Invest
ZurichSeed–Late Stage$648K – $3.2M
43 people
Catalio Capital Management, LP
New YorkSeed–Late Stage
37 people
UTokyo Innovation Platform Co. Ltd.
TokyoPre-Seed–Growth
21 people
Revelstoke Capital Partners
DenverGrowth
57 people
Optum Ventures
BostonSeed–Growth
35 people
Related lists
Growth Investors & VC Firms (4301)Growth Investors & VC Firms in North America (2155)Growth Investors & VC Firms in United States (1870)Medical Devices Investors & VC Firms (1659)Growth Investors & VC Firms in Europe (1648)Growth Investors & VC Firms in Global (1397)Medical Devices Seed Investors & VC Firms (1321)Healthtech Growth Investors & VC Firms (1282)Growth Investors & VC Firms in Asia-Pacific (1264)Enterprise Software Growth Investors & VC Firms (1211)
Data sourced from public filings and firms' own websites — see our methodology.
















































































































